Clik here to view.
通过使用安佰深集团建议的基金，赛诺龙完成了早前宣布的交易，成为一家私营公司
加利福尼亚州欧文市 (美国商业资讯)–赛诺龙医疗（纳斯达克股票代码：ELOS）为一家全球领先的非手术美容设备公司，其今天宣布，已使用安佰深集团建议的附属基金成功完成收购交易，此次收购的价格为每股11.00美元，总交易额约4亿美元。...
View ArticleClik here to view.
シネロン・キャンデラ、Apax Partnersとの資金取引完了を報告、非上場企業に。米国に拠点を置く新経営陣を発表
カリフォルニア・アーバイン （ビジネスワイヤ） –美容医療機器の代表的メーカーであるSyneron Medical社（NASDAQ：ELOS）は、本日、投資顧問会社Apax Partnersによる買収が完了したことを報告、シネロン・キャンデラ社の株は1株あたり11ドル、総額4億万ドル相当で取引された。...
View ArticleClik here to view.
Zymeworks and Daiichi Sankyo Announce Successful Achievement of a Research...
VANCOUVER, British Columbia, TOKYO and BASKING RIDGE, N.J. Zymeworks Inc. (“Zymeworks”), a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of...
View ArticleClik here to view.
Prana Commences Research Collaboration with Takeda for the Treatment of...
MELBOURNE, Australia & SAN FRANCISCO Prana Biotechnology Ltd (ASX:PBT)(NASDAQ:PRAN) today announced a research collaboration with Takeda Pharmaceuticals International, Inc. to study the ability...
View ArticleClik here to view.
FUJIFILM Corporation Announces Results from Phase II Clinical Trial of...
TOKYO FUJIFILM Corporation (TOKYO: 4901) (President: Kenji Sukeno) announced that the company’s Alzheimer’s Disease drug “T-817MA,” did not meet its primary study endpoints of cognition or global...
View ArticleClik here to view.
Vets First Choice Raises $223 Million to Fuel Expansion
PORTLAND, Maine Vets First Choice, the leading provider of technology enabled healthcare services for veterinary medicine, announced a $223 million strategic investment to accelerate growth, launch...
View ArticleClik here to view.
Masimo Announces CE Marking of Noninvasive RPVi™, a rainbow® Multi-Wavelength...
NEUCHATEL, Switzerland Masimo (NASDAQ: MASI) announced today the CE marking of RPVi™, a noninvasive and continuous measurement of the dynamic changes in perfusion index (Pi) that occur during one or...
View ArticleClik here to view.
Innovus Pharma’s Partner Luminarie Receives Approval for Zestra® for Female...
SAN DIEGO Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the “Company”) (OTCQB Venture Market: INNV), an emerging over-the-counter (“OTC”) consumer goods and specialty pharmaceutical company...
View ArticleClik here to view.
Neuland Laboratories Unveils Dedicated Process Engineering Lab
HYDERABAD, India Neuland Laboratories Limited (NLL) (NSE: NEULANDLAB; BSE-Scrip Code:524558), a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates...
View ArticleClik here to view.
Evaluate Ltd’s Epi Analyzer: Blockbusters Out, Highly Targeted Therapies In
LONDON & BOSTON & SAN FRANCISCO & TOKYO Today life science commercial intelligence leader, Evaluate, released case studies highlighting the value of granular patient segmentation and...
View ArticleClik here to view.
Masimo宣布rainbow®多波长脉搏灌注变异指数无创RPVi™获得CE标记
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，RPVi™获得CE标记，RPVi是一个或多个呼吸周期中灌注指数(Pi)所发生的动态变化的无创连续测量指标。RPVi可显示某些生理因素（例如血管张力、循环血容量、胸内压位移）的变化。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
マシモ、rainbow®対応の多派長脈波変動指標となる非侵襲的RPVi™のCEマーク取得を発表
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、RPVi™がCEマークを取得したと発表しました。RPVi™は、1回以上の呼吸周期における灌流指標（Pi）の動的変化を非侵襲的かつ連続的に測定した値です。RPViは血管緊張度、循環血液量、胸腔内圧変動などの生理学的因子を反映した変化を示すようにデザインされています。 このSmart News...
View ArticleClik here to view.
SpinalCyteが新たな日本国特許を取得
ヒューストン テキサスに拠点を置き、ヒト皮膚線維芽細胞を使用した椎間板髄核の再生に傾注する組織工学技術企業のSpinalCyte, LLCは本日、日本国特許第6151006号「生体内バイオリアクターを使用した軟骨修復のための方法と組成物」の登録を発表しました。...
View ArticleClik here to view.
美泰上市全球最先进的人参补剂
中国广州 (美国商业资讯) — 美泰® (NASDAQ: MTEX) 通过其网站www.MEITAICHINA.COM向中国家庭提供顶级品质的营养补剂，该公司宣布，GinMAX™片已在中国上市。GinMAX是一种强效的双层人参产品，属同类中首创。 这种独特的双层片剂采用世界上首款发酵白参Panax ginseng制造，并与强效发酵红参Panax...
View ArticleClik here to view.
ニューランド・ラボラトリーズがプロセスエンジニアリング専用ラボを公開
印ハイデラバード （ビジネスワイヤ） — 約80カ国の顧客に医薬品有効成分（API）、中間複合体、カスタム化製造ソリューションの各サービスを提供する製薬会社のニューランド・ラボラトリーズ・リミテッド（NLL）（NSE: NEULANDLAB、BSE-Scrip...
View ArticleClik here to view.
Samsung Bioepis Announces RENFLEXIS™ (infliximab-abda) Now Available in the...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced the launch of RENFLEXIS™ (infliximab-abda), a biosimilar referencing Remicade® (infliximab), in the United States (US). RENFLEXIS™ was...
View ArticleClik here to view.
Co-Diagnostics, Inc. Announces Joint Venture in India
SALT LAKE CITY Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic...
View ArticleClik here to view.
Takeda and BioSurfaces Announce Joint Research Program to Explore Promising...
CAMBRIDGE & ASHLAND, Mass. Takeda Pharmaceutical Company Limited (TSE: 4502) and BioSurfaces Inc. announced today that they have entered into an agreement to initiate a research program designed...
View ArticleClik here to view.
GI Dynamics Selects Proven Process Medical Devices as Contract Manufacturer
BOSTON & SYDNEY GI Dynamics® Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and...
View ArticleClik here to view.
Foxconn Selects Wisconsin with Commitment to High-Tech Manufacturing
MADISON, Wis. Foxconn Technology Group (Foxconn), has announced this afternoon that the company will be building a high-tech display manufacturing plant and technology campus in Southeastern...
View Article